Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 128

    WHO drug pricing talks may fail to end secrecy, activists fear

    WHO drug pricing talks may fail to end secrecy, activists fear

    Medical Dialogues Bureau26 May 2019 9:00 AM IST
    GENEVA: Governments are working on a drug pricing transparency deal at the World Health Organization's (WHO) annual assembly, but activists said on...
    Novartis gets USFDA nod for over Rs 13 crore gene therapy Zolgensma

    Novartis gets USFDA nod for over Rs 13 crore gene therapy Zolgensma

    Farhat Nasim25 May 2019 10:00 AM IST
    The Food and Drug Administration on Friday approved the treatment, called Zolgensma, for all children under age 2 who are confirmed by a genetic test...
    GSK, Pfizer gets CCI approval for consumer healthcare JV formation

    GSK, Pfizer gets CCI approval for consumer healthcare JV formation

    Garima25 May 2019 9:45 AM IST
    After the deal, GSK will have a majority controlling equity interest of 68 per cent in the combined consumer healthcare business, while Pfizer will...
    Novartis India Q4 profit falls 26 percent to Rs 20 crore

    Novartis India Q4 profit falls 26 percent to Rs 20 crore

    Garima25 May 2019 9:30 AM IST
    Novartis India's board has recommended a dividend of 200 per cent (Rs 10 per equity share of Rs 5 each) for the year ended March 31, 2019.New Delhi:...
    US impose sanctions on network of online pharmacies for opioids

    US impose sanctions on network of online pharmacies for opioids

    Medical Dialogues Bureau25 May 2019 9:15 AM IST
    The move was the latest effort by the Trump Administration to tackle the U.S. epidemic of abuse and overdoses linked to prescription painkillers and...
    Array BioPharmas colorectal cancer combo treatment meets main goals

    Array BioPharma's colorectal cancer combo treatment meets main goals

    Medical Dialogues Bureau25 May 2019 9:00 AM IST
    U.S: Array BioPharma Inc's cocktail of three therapies helped patients with a type of colorectal cancer live longer than those on standard treatment,...
    JnJ loses talc verdict in New York; to pay over Rs 174 crore: Bloomberg

    JnJ loses talc verdict in New York; to pay over Rs 174 crore: Bloomberg

    Farhat Nasim24 May 2019 11:36 AM IST
    JnJ faces more than 14,000 claims that its powders caused ovarian cancer and mesothelioma, rare cancer linked to asbestos exposure.New Delhi: Johnson...
    GSK reintroduce incentives for sales representatives

    GSK reintroduce incentives for sales representatives

    Farhat Nasim24 May 2019 9:31 AM IST
    GSK said it would make changes to its incentive program for pharmaceutical and vaccines sales representatives, to be applied initially in the United...
    Cipla to acquire 26 percent stake in AMP Solar Power Systems

    Cipla to acquire 26 percent stake in AMP Solar Power Systems

    Garima24 May 2019 9:30 AM IST
    Cipla will acquire and maintain 26 per cent stake on a fully diluted basis in AMPSolar throughout the term of the power purchase agreement, share...
    Torrent Pharma posts Q4 net loss of Rs 152 crore

    Torrent Pharma posts Q4 net loss of Rs 152 crore

    Garima24 May 2019 9:15 AM IST
    The company had posted a net profit of Rs 228 crore for the corresponding period of the previous fiscal, Torrent Pharma said in a filing to the...
    China M&A crimp due to data quality, lagging regulatory standards; says Novartis CEO

    China M&A crimp due to data quality, lagging regulatory standards; says Novartis CEO

    Medical Dialogues Bureau24 May 2019 9:00 AM IST
    Novartis has 14 medicines listed in China, including top-selling psoriasis and arthritis medicine Cosentyx, a development helped as Chinese regulators...
    Zydus Cadila gets USFDA approval for Esomeprazole Magnesium delayed-release capsules

    Zydus Cadila gets USFDA approval for Esomeprazole Magnesium delayed-release capsules

    Farhat Nasim23 May 2019 12:15 PM IST
    The company said Esomeprazole belongs to the group of medicines termed as proton pump inhibitors.New Delhi: Zydus Cadila has received final approval...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Ministry of AYUSH invites initial bids for strategic sale of IMPCL

    Ministry of AYUSH invites initial bids for strategic sale of IMPCL

    OncoStem Diagnostics named

    OncoStem Diagnostics named 'Best Innovation- Cancer Risk Assessment' by NASSCOM Life sciences and...

    Protect Your Loved Ones with a Term Plan that’s Smart

    Protect Your Loved Ones with a Term Plan that’s Smart

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients

    FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok